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Objective : To determine whether the outcomes of percutaneous epidural neuroplasty (PEN) are influenced by the type of lumbar 
disc herniation (LDH) and evaluate the effectiveness of PEN in patients with single-level LDH.
Methods : This study included 430 consecutive patients with single-level LDH who underwent PEN. Before treatment, the LDH 
type was categorized as bulging, protrusion, extrusion, and sequestration, while Pfirrmann grades were assigned according to 
imaging findings. Visual analog scale (VAS) scores for back and leg pain and success rates (Odom’s criteria) were assessed at 1, 3, 6, 
and 12 months after treatment.
Results : The mean preoperative VAS scores for back and leg pain were 6.90 and 4.23, respectively; these decreased after PEN as 
follows : 2.25 and 1.45, respectively, at 1 month; 2.61 and 1.68, respectively, at 3 months; 2.28 and 1.48, respectively, at 6 months; 
and 2.88 and 1.48, respectively, at 12 months (p<0.001). The decrease in VAS scores for leg pain was significantly greater in the 
extrusion and sequestration groups than in the other two groups (p<0.05); there were no other significant differences among 
groups. More than 70% patients exhibited good or excellent 12-month outcomes according to Odom’s criteria. Subsequent surgery 
was required for 59 patients (13.7%), with a significantly higher rate in the extrusion (25.0%) and sequestration (30.0%) groups than 
in the bulging (7.3%) and protrusion (13.8%) groups (p<0.05). Nevertheless, subsequent surgery was not required for >70% patients 
with extrusion or sequestration. Patients with Pfirrmann grades 1–3 (14.0–21.5%) showed a significantly higher rate of subsequent 
surgery than those with Pfirrmann grade 0 (4.9%; p<0.05). 
Conclusion : Our findings suggest that PEN is an effective treatment for back and leg pain caused by single-level LDH, with the 
outcomes remaining unaffected by the LDH type.
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INTRODUCTION
Back pain affects millions of individuals and is one of the 
most common conditions prompting patients to seek medical 
attention2,28). Up to 80% individuals are affected by back pain 
during their lives, with the prevalence of low back pain in-
creasing by 2–5% every year1). Furthermore, over 80% affected 
patients report recurrent episodes6). The National Center for 
Health Statistics has documented back and spine impairments 
as the most frequent causes of limitations in daily activities 
among individuals aged <45 years1).
Lumbar disc herniation (LDH) occurs in several cases of 
lumbar nerve root compression, and it accounts for 4% cases 
of low back pain. Spinal canal stenosis and post-laminectomy 
syndrome are also known to compress the lumbar spinal root. 
In addition, scar tissue formed around nerve roots may irri-
tate them and cause continuous neuropathic pain, while ad-
hesions formed after spine surgery can cause chronic inflam-
mation and nerve root irritation. For patients with low back 
pain in the absence of neurological abnormalities, conserva-
tive treatment with different epidural injection techniques 
could be useful.
Percutaneous epidural neuroplasty (PEN) is a minimally 
invasive therapy wherein a catheter is directly placed into the 
herniated disc or scar tissue compromising the nerve root. In 
the cervical study, it has been found that PEN treatment im-
proves the patient’s visual analog scale (VAS) score and Odom’s 
score23). It has been used for patients with refractory chronic 
low back pain or failed back surgery syndrome5,7,8,11,14-17,19,21,27). 
A systematic review found level I evidence for the effectiveness 
of percutaneous adhesiolysis in the treatment of chronic re-
fractory low back and lower extremity pain. Accordingly, the 
authors recommended PEN as a first-line treatment for these 
conditions14). The goal of PEN is to ameliorate aberrant adhe-
sions, which can physically impede the direct application of 
drugs around the nerves, and deliver medication to the target-
ed site4,13,22,29). Thus, this procedure can result in pain reduc-
tion and functional improvement in patients with chronic 
lower back or leg pain due to LDH20).
However, to the best of our knowledge, no long-term clini-
cal study has observed the outcomes of PEN in patients with 
LDH or determined whether the type of LDH influences the 
outcomes of PEN. Therefore, we conducted the present 
12-month follow-up study to determine whether the LDH 
type influences the clinical outcomes of PEN and to evaluate 
the effectiveness of PEN in patients with single-level LDH. 
MATERIALS AND METHODS
The Institutional Review Board of Cham Teun Teun Hos-
pital approved the study (IRB-No. GTIRB-13-005). This ret-
rospective observational study included patients with single-
level LDH who underwent PEN between February 2010 and 
March 2011 and were followed-up for >12 months at a single 
hospital. Data were collected from medical charts, radiologi-
cal images, and surgeons’ personal records. The inclusion cri-
teria for the study were as follows : age >18 years, diagnosis of 
single-level LDH with radicular pain or radiculopathic symp-
toms ineffective to conservative treatment for at least 1 month, 
and ability to provide written informed consent for participa-
tion in a clinical trial when the presence of adhesion was sus-
pected. Patients with multi-level LDH, lumbar stenosis, spinal 
cord lesions, hyaluronic acid-sensitive side effects, uncon-
trolled diabetes, and previous lumbar surgeries were excluded.
Single-level LDH was diagnosed on the basis of clinical 
symptoms, neurological examinations, and imaging studies 
including radiography and magnetic resonance imaging 
(MRI). MRI findings were analyzed for the type of LDH and 
Pfirrmann grade25).
The LDH type was categorized as follows : bulging, defined 
as “an out-pouching not compressed against the nerves and 
occurring with the spinal disc and associated ligaments in-
tact” (n=124); protrusion, defined as “an out-pouching pressed 
against the nerves and occurring with the spinal disc and as-
sociated ligaments intact” (n=240); extrusion, defined as “disc 
extrusion where the outer part of the spinal disc is ruptured, 
allowing the inner, gelatinous part of the disc to squeeze out” 
(n=56); and sequestration, defined as “disc sequestration 
where the center, gelatinous portion of the disc is not only 
squeezed out but also separated from the main part of the 
disc” (n=10). The Pfirrmann grade was assigned as follows: 
grade 0, normal, “no compromise of the nerve root is seen” 
(n=123); grade 1, contact, “visible contact of disc material with 
the nerve root without evidence of the normal epidural fat 
layer between the two” (n=86); grade 2, deviation, “nerve root 
displaced dorsally by disc material” (n=128); and grade 3, 
compression, “compressed nerve root between the disc mate-
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rial and the wall of the spinal canal; it may appear flattened or 
may be indistinguishable from the disc material” (n=93).
The VAS (score range, 0 to 10, with 0 reflecting no pain) for 
back pain (VAS back) and leg pain (VAS leg), as well as the 
clinical outcome based on Odom’s criteria, which classifies 
outcomes as excellent, good, fair, or poor, were used to evalu-
ate the clinical effectiveness of PEN with regard to pain reduc-
tion and functional improvement. VAS scores were recorded 
before and 1, 3, 6, and 12 months after PEN, while clinical 
outcomes were evaluated 1, 3, 6, and 12 months after PEN. All 
patients were asked to provide responses based on the average 
severity of symptoms over the week prior to their visit. Suc-
cessful pain relief was described as a ≥50% decrease in the 
VAS score, while good or excellent outcomes according to 
Odom’s criteria were considered to reflect a “good” outcome.
PEN was performed under fluoroscopic guidance in a ster-
ile operating room with monitoring equipment for blood 
pressure, pulse rate, and pulse oximetry. The fluoroscope was 
adjusted over the lumbosacral area such that a caudal ap-
proach could be used in both the anteroposterior and lateral 
views. Following appropriate positioning of the f luoroscope, 
the needle insertion site was determined around the sacral hi-
atus and was injected with local anesthetics. An RK® needle 
(Epimed International Inc., Gloversville, NY, USA) was intro-
duced into the caudal epidural space under fluoroscopic guid-
ance. On confirmation of the needle position in the epidural 
space, lumbar epidurography was performed with approxi-
mately 5 mL of a noniodinated contrast agent (IOBRIX®, AC-
CUZEN, Seoul, Korea). Filling defects were identified through 
observation of contrast f low into the nerve root (Fig. 1). We 
confirmed that there was no intravascular or subarachnoid 
placement of the needle; if such malpositioning was observed, 
the needle was repositioned. Following epidurography and 
confirmation of appropriate needle positioning, a Racz cathe-
ter (Epimed International Inc.) was advanced through the RK 
needle to the area of the filling defect or the site of pathology 
as determined by MRI. Then, adhesiolysis was performed, af-
ter which final positioning of the catheter was achieved in the 
lateral and ventral epidural spaces. Following satisfactory posi-
tioning of the catheter, at least 3 mL of contrast agent was in-
jected. If there was no subarachnoid, intravascular, or other 
extra-epidural filling, and if satisfactory filling was observed 
in the target regions, 6 mL of 0.2% preservative-free ropiva-
caine containing 1500 units of hyaluronidase and 4 mL of be-
tamethasone sodium phosphate was injected. An hour after 
the procedure, 6 mL of 8% sodium chloride solution was in-
Fig. 1. A specially designed spring-wire catheter (Racz catheter®; Epimed International Inc., Gloversville, NY, USA) needle was introduced into the sacral 
epidural space under fluoroscopy. Once the needle placement was confirmed to be in the epidural space, a lumbar epidurogram was carried out with 
contrast. Identification of the filling defects was carried out by examining the contrast flow into the nerve roots. After appropriate determination of 
epidurography, a Racz catheter was slowly passed through the needle to the intended area, and adhesiolysis and scheduled injection were carried out.
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fused over 30 minutes under monitoring in the recovery 
room. The intravenous line and epidural catheter were re-
moved, and the patient was discharged when all parameters 
were observed to be satisfactory. The first follow-up visit was 
scheduled at 2 weeks after the procedure. During these 2 
weeks, all patients received nonsteroidal anti-inf lammatory 
drugs and muscle relaxants in equal doses to reduce proce-
dure-related pain.
Student’s t-test, analysis of variance (ANOVA), and the chi-
square test were used to estimate the reliability of the radio-
logical and clinical outcomes. Student’s t-test was used to 
compare demographic data between pairs of groups; ANOVA 
was used to compare VAS back and leg scores, Pfirrmann 
grades, success rates (Odom’s criteria), and symptom duration 
among the LDH types; and the chi-square test was used to 
compare VAS back and leg scores and the rates of hyperten-
sion, diabetes mellitus, tuberculosis, and hepatitis among the 
LDH types. All statistical analyses were performed using SPSS 
software (SPSS Inc., Chicago, IL, USA). A p-value of <0.05 was 
considered statistically significant.
RESULTS
In total, 430 patients were enrolled. One-, 3-, 6-, and 
12-month follow-up data were available for 430, 408, 385, and 
371 patients, respectively. Table 1 summarizes the demograph-
ic data for these patients. The average age at treatment was 
46.7 years, and the men versus women ratio was 49.5%. Con-
secutive target levels were as follows : L1/2 and L2/3, n=4; L3/4, 
n=30; L4/5, n=269; and L5/S1, n=123. Among these patients, 
375 (87.2%) received a single nerve root block prior to adhe-
siolysis.
With regard to the LDH type, there were 124 patients with 
Table 1. Demographic data
Case Value (n=430)
Male ratio 213 (49.5)
Mean age 46.7±13.8
Symptom duration (months) 2.8±0.5
Level
L1/2 4 (0.93)
L2/3 4 (0.93)
L3/4 30 (6.98)
L4/5 269 (62.56)
L5/S1 123 (28.60)
Comorbidity
Hypertension 77 (17.91)
Diabetes mellitus 126 (29.03)
Tuberculosis 11 (2.56)
Hepatitis 13 (3.02)
Complete follow-up patients
1 month 430
3 months 408
6 months 385
12 months 371
Values are presented as mean±standard deviation or number (%)
Table 2. Demographic data according to the type of single level disc herniation
Category Bulging Protrusion Extrusion Sequestration Total
Cases 124 240 56 10 430
Male ratio 56 (45.16) 115 (47.92) 36 (64.29) 6 (60.00) 213 (49.50)
Mean age 51.5±13.3 45.4±13.6 46.7±13.8 46.7±13.8 46.7±13.8
Symptom duration (months) 3.2±0.2 2.7±0.5 3.1±0.4 1.9±0.1 2.8±0.5
Complete follow-up
1 month 124 240 56 10 430
3 months 120 232 47 9 408
6 months 117 215 45 8 385
12 months 115 207 42 7 371
Operated cases 9 (7.26) 33 (13.75) 14 (25.00) 3 (30.00) 59 (13.72)
Values are presented as mean±standard deviation or number (%)
  PEN Outcomes According to LDH Type | Cho PG, et al.
685J Korean Neurosurg Soc 62 (6) : 681-690
bulging, 240 with protrusion, 56 with extrusion type, and 10 
with sequestration (Table 2). The men versus women ratios 
and mean age were 45.2% and 51.5±13.3 years, respectively, in 
the bulging group; 47.9% and 45.4±13.6 years, respectively, in 
the protrusion group; 64.3% and 46.7±13.8 years, respectively, 
in the extrusion group; and 60.0% and 46.7±13.8 years, re-
spectively, in the sequestration group. The men versus women 
ratio was significantly different between the bulging and ex-
trusion groups and the protrusion and extrusion groups, 
while the mean age was significantly different between the 
bulging and protrusion groups and the bulging and extrusion 
groups. There were no other significant differences. A total of 
59 patients (13.7%) underwent subsequent surgical decom-
pression for severe pain during the follow-up period, and their 
clinical data were excluded from the date of the surgery. Nine 
(7.3%), 33 (13.8%), 14 (25.0%), and three (30.0%) patients with 
bulging protrusion, extrusion, and sequestration, respectively, 
required surgical decompression during the follow-up period. 
Thus, 12-month clinical follow-up data were available for 115 
(92.7%), 207 (86.3%), 42 (75.0%), and seven (70.0%) patients 
with bulging, protrusion, extrusion, and sequestration, re-
spectively (Fig. 2). The rate of subsequent surgery was relative-
ly high for the extrusion and sequestration groups, with sig-
nificant differences between the bulging and extrusion groups 
(p<0.001), bulging and sequestration groups (p=0.015), and 
protrusion and extrusion groups (p=0.038). Nevertheless, 
>70% patients in the extrusion and sequestration groups did 
not require surgery during the 12-month follow-up period.
With regard to the Pfirrmann grade, there were 123 patients 
with Pfirrmann grade 0, 86 with Pfirrmann grade 1, 128 with 
Pfirrmann grade 2, and 93 with Pfirrmann grade 3. Surgical 
decompression during the 12-month follow-up period was re-
quired for six (4.88%), 12 (13.95%), 21 (16.41%), and 20 
(21.51%) patients with Pfirrmann grades 0, 1, 2, and 3, respec-
tively. Thus, the rate of subsequent surgery according to the 
Pfirrmann grade was significantly different between patients 
Fig. 2. Flow sheet of surgical decompression and follow-up during 12 months. f/up : follow-up.
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with grade 0 and those with grades 1 (p=0.021), 2 (p=0.003), 
and 3 (p<0.001).
The results of clinical assessments are summarized in Figs. 
3-6. The overall mean VAS scores for back and leg pain were 
6.9 and 4.2, respectively, before treatment; 2.3 and 1.5, respec-
tively, at 1 month; 2.6 and 1.7, respectively, at 3 months; 2.3 
and 1.5, respectively, at 6 months; and 2.9 and 1.5, respectively, 
at 12 months (all p<0.001 vs. the preoperative scores, Fig. 3). 
With regard to the LDH type, the mean preoperative VAS 
scores for back and leg pain improved at 12 months after 
treatment as follows (Fig. 4) : 6.9 and 3.9 to 2.9 and 1.5, respec-
tively, in the bulging group; 6.9 and 4.3 to 2.9 and 1.4, respec-
tively, in the protrusion group; 7.0 and 4.8 to 2.9 and 2.0, re-
spectively, in the extrusion group; and 6.8 and 4.0 to 1.1 and 
0.0, respectively, in the sequestration group (all p<0.001 vs. the 
preoperative scores). With regard to the Pfirrmann grade, the 
mean preoperative VAS scores for back and leg pain improved 
at 12 months after treatment as follows (Fig. 5) : 6.9 and 3.5 to 
2.9 and 1.3, respectively, in the grade 0 group; 6.9 and 4.1 to 2.4 
and 1.2, respectively, in the grade 1 group; 6.9 and 4.6 to 3.0 
and 1.6, respectively, in the grade 2 group; and 6.8 and 4.9 to 
2.4 and 1.9, respectively, in the grade 3 group (all p<0.001 vs. 
the preoperative score). The overall rates of a “good” outcome, 
defined by Odom’s criteria for a good or excellent outcome, 
were 81.3% at 1 month, 73.1% at 3 months, 74.8% at 6 months, 
and 71.7% at 12 months after PEN (Fig. 6), with no significant 
differences among the LDH types (p=0.104).
DISCUSSION
In the present study, we found that PEN is an effective treat-
ment for back and leg pain caused by single-level LDH, re-
gardless of the LDH type.
PEN has been used to treat chronic back pain refractory to 
other conservative management strategies and has been 
shown to have good clinical efficacy31). In fact, the procedure 
has demonstrated superior effectiveness over not only physical 
therapy30) but also caudal epidural steroid injections for the 
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treatment of chronic lower back and leg pain16,21). This can be 
attributed to the ability of PEN to eliminate adhesions or fi-
brous tissue that can impede the spread of medications inject-
ed into the specific lesion site. Moreover, PEN allows for the 
placement of the catheter tip within the target area. These fac-
tors enable the delivery of an adequate concentration of ste-
roid or other solution to the appropriate target area5). Howev-
er, PEN is considered more invasive and expensive than are 
conventional blocks; therefore, it is usually performed for pa-
tients who fail to respond to conservative treatment and con-
ventional injections. Although a previous study by Lee and 
Lee12) has attempted to evaluate the efficacy of PEN in patients 
unresponsive to transforaminal epidural injections, to the best 
of our knowledge, no long-term studies have attempted to as-
sess the clinical outcomes of PEN according to the type of 
LDH.
In the present study, patients were categorized according to 
the LDH type (bulging, protrusion, extrusion, and sequestra-
tion) and Pfirrmann grade (grades 0–3). The results revealed 
similar clinical outcomes for all patients, regardless of the 
LDH type or Pfirrmann grade. The only difference was ob-
served in the rate of subsequent surgical decompression dur-
ing the 12-month follow-up period; patients with extrusion or 
sequestration and those with a high Pfirrmann grade exhibit-
ed higher rates. These results are similar to those of Lee and 
Lee12), who categorized LDH as follows : bulging, protrusion, 
and extrusion; central, subarticular, and foraminal location; 
and abutment, displacement, and compression of root. They 
found that the LDH type did not influence the PEN outcome 
at 2 weeks and 3 months. In the present 12-month follow-up 
study, surgical decompression during the follow-up period 
was required for 7.3% patients with bulging, 13.8% patients 
with protrusion, 25.0% patients with extrusion, 30.0% pa-
tients with sequestration, 4.9% patients with Pfirrmann grade 
0, 14.0% patients with Pfirrmann grade 1, 16.4% patients with 
Pfirrmann grade 2, and 21.5% patients with Pfirrmann grade 
3. Although the rate of subsequent surgery differed signifi-
cantly between the bulging and extrusion groups, bulging and 
sequestration groups, protrusion and extrusion groups, and 
Fig. 5. Mean VAS scores for back pain (A) and leg pain (B) according to Pfirrmann grade during 12 months of follow-up. *Indicates a statistical difference 
of less than 0.050 between groups. VAS : visual analog scale.
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Pfirrmann grade 0 and other Pfirrmann grade groups, >70% 
patients with extrusion or sequestration did not require surgi-
cal treatment during the 12-month follow-up period after 
PEN. Extrusion and sequestrated type discs may not require 
surgical treatment because self-resolution occurs more often 
than other types26). In our clinical set-up, we usually recom-
mend surgical treatment to patients with extrusion or seques-
tration, because we believe that surgery is more effective than 
PEN in these cases. However, some of these patients refused 
surgical treatment and were consequently included in our 
study. Therefore, the number of patients with extrusion or se-
questration was smaller in the present study than in other 
studies3,24), and, consequently, a high rate of subsequent sur-
gery was recorded for these patients. This outcome indicated 
that surgery is a good treatment modality for such cases; how-
ever, a relatively high percentage of patients who are generally 
recommended surgical treatment demonstrated very impres-
sive results with PEN. This suggests that surgery may not al-
ways be necessary for such cases. 
In the present study, we investigated the clinical outcomes 
of PEN not only according to the type of single-level LDH but 
also the efficacy of PEN. All patients demonstrated significant 
improvements in VAS scores for back pain and leg pain at 12 
months after PEN. The overall success rates based on Odom’s 
criteria for good and excellent outcomes were also >70% dur-
ing the 12-month follow-up period. Studies on the clinical ef-
ficacy of PEN have reported that the procedure offers more 
significant pain reduction and better functional outcomes 
than do medication, physical therapy, and exercise pro-
grams9,18,30). Heavner et al.9) suggested that approximately 49% 
of patients who failed to achieve clinical improvement via 
other conservative treatments showed a significant decrease in 
their pain scores at 3 months, while 43% and 49% reported 
pain reduction at 6 and 12 months, respectively. A few studies 
have also compared the efficacy of PEN with that of epidural 
steroid injections. Specifically, two reports have identified that 
the clinical outcomes of PEN are better than those of caudal 
epidural injections in patients with spinal stenosis and lumbar 
postlaminectomy syndrome16,21). This efficacy was also ob-
served in the present study of patients with single-level LDH, 
who demonstrated significantly improved VAS scores for leg 
and back pain at 12 months after PEN. The overall success 
rate also remained >70% during the 12-month follow-up peri-
od. A previous study by Lee and Lee12) also reported signifi-
cant improvements in VAS back, VAS leg, and Oswestry Dis-
ability Index scores at 3 months after PEN. However, some 
studies have shown different results. Recently, Helm Ii et al.10) 
conducted a systematic review to evaluate the efficacy of PEN 
for the management of chronic low back pain in patients with 
post-lumbar surgery syndrome and spinal stenosis. The au-
thors included five randomized controlled trials and two ob-
servational studies and found fair evidence of the effectiveness 
of PEN in providing relief from low back and/or leg pain 
caused by post-lumbar surgery syndrome or spinal stenosis. 
However, they also reported a low rate of complications that 
were generally minimal and self-limiting. Therefore, well-de-
signed randomized controlled studies as well as systematic re-
views of such studies are necessary for resolution of controver-
sies concerning the efficacy of PEN.
This study has several limitations. First, it was a retrospec-
tive analysis. Second, a control group was not included for 
comparison, so improved clinical outcomes after PEN could 
not be distinguished from the natural course of LDH. Third, 
the distribution of patients according to the level and type of 
LDH was uneven, and this may have affected the statistical re-
sults. Fourth, this study did not take the MRI after procedure 
for checking the spontaneous regression of disc. This regres-
sion can affect the PEN effect according the disc type. Despite 
these limitations, however, our findings have some important 
clinical implications. We initially considered that the efficacy 
of PEN would differ with the type of LDH and Pfirrmann 
grade, whereas the actual findings contradicted our hypothe-
sis. In fact, the clinical outcomes of extrusion and sequestra-
tion, which we generally consider as strong predictors of a 
poor outcome after PEN, were found to be excellent. 
CONCLUSION
The findings of this study suggest that PEN is an effective 
treatment strategy for patients with back and leg pain caused 
by single-level LDH who do not respond to conservative treat-
ment, thus negating the need for lumbar surgery. Moreover, 
they indicate that the efficacy of PEN remains unaffected by 
the type of single-level LDH. 
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